Moderna Call Flow Hits 71% as Shares Retreat From High
Moderna, Inc. shares retreated from a $280.80 52-week high, while $26.0 million in options premium carried a 71% call tilt on Nov. 9. Key support sits at $253.33 and $237.65.
Topic
Mrna
Topic
Mrna
Sensible Biotechnologies Raises $47 Million With In-Q-Tel Backing
Sensible Biotechnologies secured $47 million, with In-Q-Tel and OTB Ventures in a Series A plus up to $20 million from Slovakia a…
Jetstream Venture Fund Backs Telomere-Targeting mRNA Startup
Jetstream Venture Fund has invested in Stanford spinout Rejuvenation Technologies, adding a telomere-extending mRNA platform to i…